Acquired Heart Disease | MyMerci
제안하기
0 / 2000

Acquired Heart Disease

Unit 4 · Topic 28Acquired Heart Disease
1.Overview & Pathophysiology

Acquired heart disease develops after birth in a structurally normal heart, usually from inflammation, infection, or lifestyle-related risk factors. In high-income countries Kawasaki disease is the leading cause of acquired heart disease in children; worldwide, rheumatic heart disease remains the most common.

Kawasaki disease (KD) — an acute, self-limited vasculitis of medium-sized arteries of unknown cause, occurring mostly in children under 5 years, more often in boys and in children of East Asian ancestry. Its main danger is coronary artery aneurysm, which develops in about a quarter of untreated children and far fewer when IVIG is given early. Aneurysms can thrombose or rupture, causing myocardial infarction or sudden death.

PhaseTimingFeatures
AcuteWeeks 1–2High fever unresponsive to antipyretics, marked irritability, conjunctival injection, oral changes, rash, swollen red hands and feet, cervical node
SubacuteWeeks 2–4Fever resolves; peeling of fingers and toes, thrombocytosis; highest risk of aneurysm and thrombosis
ConvalescentUntil labs normalize (6–8 weeks)Signs gone; follow-up of coronary arteries

Acute rheumatic fever (ARF) — an autoimmune reaction 2–4 weeks after untreated group A streptococcal (GAS) pharyngitis. Antibodies against streptococcal antigens cross-react with heart, joints, brain, and skin (molecular mimicry). Carditis is the only manifestation that can cause permanent damage — scarring of the mitral (most often) and aortic valves → rheumatic heart disease (RHD). Recurrences with each new strep infection add damage, so secondary prophylaxis is the key to prevention. (Adult RHD: Medical-Surgical topic "Inflammatory Heart Disease.")

Other acquired conditions

  • Infective endocarditis — infection of the endocardium or valves; higher risk with CHD (especially cyanotic, prosthetic material), central lines, and poor dental health
  • Myocarditis — usually viral; can present with heart failure, arrhythmia, or chest pain
  • Multisystem inflammatory syndrome in children (MIS-C) — follows SARS-CoV-2 infection by 2–6 weeks; fever, GI symptoms, rash, shock, and myocardial dysfunction; overlaps with Kawasaki disease
  • Cardiomyopathy (dilated, hypertrophic) — inherited or acquired; hypertrophic cardiomyopathy is a cause of sudden death in young athletes
  • Hypertension and dyslipidemia — rising with childhood obesity; begin the process of adult cardiovascular disease

Shock — circulatory failure from hypovolemia (most common in children: diarrhea, bleeding), sepsis, or cardiac failure. Children compensate with tachycardia and vasoconstriction, so blood pressure falls only late.

2.Assessment Findings

Kawasaki disease — diagnosis: fever for 5 days or more plus at least 4 of 5 principal features

  1. Bilateral conjunctival injection without discharge (limbal sparing)
  2. Oral changes: red, dry, cracked lips, strawberry tongue, red oral mucosa
  3. Polymorphous rash (trunk, perineum); not vesicular
  4. Extremity changes: red palms and soles and swelling of hands and feet (acute); peeling of fingers and toes (weeks 2–3)
  5. Cervical lymphadenopathy, at least 1.5 cm, usually unilateral and nonsuppurative

Incomplete KD (fewer features, common in infants under 6 months) is diagnosed with lab and echo findings — infants have the highest aneurysm risk. Other findings: extreme irritability, arthritis, abdominal pain, gallbladder hydrops, sterile pyuria, and tachycardia or gallop (myocarditis).

Rheumatic fever — Jones criteria (2015 revision): evidence of recent GAS infection plus 2 major, or 1 major and 2 minor criteria

  • Major: carditis (clinical or on echocardiogram — new murmur, tachycardia out of proportion to fever), migratory polyarthritis of large joints, Sydenham chorea (involuntary jerky movements, emotional lability — can appear months later), erythema marginatum (pink rings with clear centers on trunk), subcutaneous nodules (painless, over bony prominences)
  • Minor: fever, arthralgia, raised ESR or CRP, prolonged PR interval
  • In moderate- and high-risk populations, monoarthritis or polyarthralgia can count as major

Shock and perfusion

  • Early (compensated): tachycardia, capillary refill over 2 seconds, weak peripheral pulses, cool extremities with a warm trunk, decreased urine output, irritability
  • Late (hypotensive): low BP, lethargy, mottling, bradycardia (pre-arrest)
  • Warm septic shock: flash capillary refill, bounding pulses, wide pulse pressure; cold shock: delayed refill, weak pulses, cool mottled skin

Pediatric hypertension — elevated BP (90th to below 95th percentile, or 120/80 or higher in adolescents 13 and older); stage 1 at or above the 95th percentile (or 130/80 in adolescents). Measure with the correct cuff size — a cuff that is too small gives a falsely high reading.

3.Diagnostics
TestKey points
Echocardiogram (Kawasaki)At diagnosis, 1–2 weeks, and 4–6 weeks after; coronary size is measured as z-scores; more often if aneurysms
Kawasaki labsRaised CRP and ESR, leukocytosis, anemia, low albumin, raised ALT, sterile pyuria, platelets rise after the first week
Evidence of GAS infection (ARF)Raised or rising antistreptolysin O (ASO) or anti-DNase B titers, positive throat culture or rapid test
ECGProlonged PR interval (ARF), ischemia or arrhythmias (KD, myocarditis)
Blood cultures (endocarditis)Multiple sets before antibiotics
Troponin, BNPMyocarditis, MIS-C
Lactate, blood culture, glucoseSeptic shock
Lipid screeningUniversal once between ages 9 and 11 and again at 17–21; earlier with family history
4.Medical Management

Kawasaki disease (AHA 2024 update)

  • IVIG 2 g/kg as a single infusion over 8–12 hours, ideally within the first 10 days of fever (still given after day 10 if fever or inflammation persists)
  • Aspirin: moderate dose (30–50 mg/kg/day) or high dose (80–100 mg/kg/day) during the acute febrile phase, then low dose (3–5 mg/kg/day) as an antiplatelet agent until follow-up echo shows no coronary changes (about 4–6 weeks). The benefit of acute-phase aspirin on coronary outcomes is debated, but it remains part of standard therapy
  • High-risk children (young infants, early aneurysms): add corticosteroids tapered over 2–3 weeks
  • IVIG-resistant KD (fever 36 hours or more after the infusion): second IVIG dose, corticosteroids, or infliximab
  • Large aneurysms: anticoagulation (warfarin or low-molecular-weight heparin) with low-dose aspirin; long-term cardiology follow-up

Acute rheumatic fever

  • Eradicate GAS: benzathine penicillin G IM once (dose as in secondary prophylaxis below) or oral penicillin for 10 days
  • Arthritis: aspirin or naproxen (dramatic response supports the diagnosis)
  • Carditis: rest and limited activity until inflammation settles; heart failure treatment; corticosteroids for severe carditis in some protocols
  • Chorea: quiet, safe environment; medication for severe cases
  • Secondary prophylaxis — benzathine penicillin G IM every 4 weeks (every 3 weeks in high-risk settings): 27 kg (60 lb) or less: 600,000 units; over 27 kg: 1.2 million units (AHA/IDSA, US; WHO 2024 uses under 30 kg / 30 kg or more) to prevent recurrence and valve damage. Duration: no carditis — 5 years or until age 21; carditis without residual valve disease — 10 years or until 21; residual valve disease — 10 years or until age 40, sometimes lifelong (whichever is longer). Oral penicillin or erythromycin if injections are impossible

Infective endocarditis — prolonged IV antibiotics (4–6 weeks) guided by cultures; surgery for valve destruction.

Septic shock — recognize early; antibiotics within 1 hour; isotonic crystalloid boluses of 10–20 mL/kg, reassessing after each for improvement and for fluid overload (crackles, liver enlargement); epinephrine or norepinephrine is preferred over dopamine for fluid-refractory shock.

Hypertension — lifestyle change (DASH-type diet, less sodium, activity, weight management); medication (ACE inhibitor, ARB, calcium channel blocker, thiazide) for stage 2, symptoms, or failed lifestyle change.

Drug safety (doses weight-based and verified against a pediatric reference)

DrugKey safety points
IVIGBlood product — infusion reactions like transfusion reactions (fever, chills, headache, flushing, hypotension, anaphylaxis): start slowly, increase rate per protocol, vital signs before, frequently during, and after; aseptic meningitis, hemolytic anemia, fluid overload, thrombosis. Delay live vaccines (MMR, varicella) for 11 months after 2 g/kg
AspirinGI irritation, bleeding; Reye syndrome risk with influenza or varicella — give inactivated influenza vaccine (not live) and report exposure to chickenpox or flu; avoid ibuprofen (blocks aspirin's antiplatelet effect); stop before surgery as directed
Benzathine penicillin GDeep IM only, never IV; painful — warm to room temperature; allergy/anaphylaxis — observe 15–30 minutes after injection
CorticosteroidsHyperglycemia, hypertension, mood change, infection; long courses need tapering
WarfarinBleeding; INR monitoring; many drug and food (vitamin K) interactions; teratogenic
Epinephrine / norepinephrine infusionsTachyarrhythmias, hypertension, tissue ischemia; central line preferred; extravasation → necrosis
ACE inhibitorsHypotension, hyperkalemia, cough, angioedema; teratogenic — pregnancy testing and contraception counseling for adolescents
5.Nursing Interventions

Listed in priority order.

  1. Circulation and cardiac function
    • Monitor HR and rhythm, BP, perfusion, SpO₂, and signs of heart failure (tachypnea, hepatomegaly, gallop, edema); report chest pain, arrhythmias, or signs of myocardial ischemia (in infants: irritability, pallor, vomiting)
    • Shock: position flat, oxygen, IV or intraosseous access, fluid boluses and antibiotics as ordered; reassess after each bolus
  2. IVIG infusion safety — verify product and dose, use a pump, titrate the rate, monitor vital signs, and stop the infusion and notify the provider for a reaction
  3. Fever and comfort (KD)
    • Monitor temperature (every 4 hours or as ordered) and fever pattern — fever lasting 36 hours or more after IVIG suggests resistance
    • Minimize stimulation: the child is very irritable; cluster care, quiet room, parental presence
    • Lip and mouth care: lubricant on cracked lips, soft cool foods and fluids, mouth rinses
    • Skin: keep peeling skin clean; do not pull; lotion as allowed
    • Monitor intake, output, and weight (fluid overload with IVIG, poor intake)
  4. Joint and neurologic care (ARF)
    • Support painful joints; avoid pressure from bedclothes; give anti-inflammatory drugs as ordered
    • Chorea: protect from injury (padded rails), assist with feeding and self-care, explain that movements are involuntary and temporary
    • Balance rest with quiet activities during carditis
  5. Record and coordinate prophylaxis — dates of each injection, reminders, and follow-up
6.Client Education
  • Kawasaki: irritability may continue for weeks; peeling of fingers and toes is expected; continue low-dose aspirin as prescribed; do not give ibuprofen; report fever, vomiting, or exposure to chickenpox or influenza; get the yearly inactivated influenza vaccine; delay live vaccines for 11 months after IVIG; keep all echocardiogram appointments
  • Rheumatic fever: never miss a prophylaxis injection — each missed dose risks a recurrence and more valve damage; treat any sore throat promptly; keep excellent dental hygiene; tell every provider about the history
  • Children with valve damage: ask the cardiologist about endocarditis prophylaxis (only certain high-risk conditions qualify)
  • Heart-healthy habits: balanced diet low in salt and saturated fat, 60 minutes of daily activity, no tobacco or vaping, healthy weight; BP checks at every yearly visit from age 3
7.Complications & Red Flags
ComplicationWhat to watch for
Coronary artery aneurysm / thrombosis (KD)Chest pain, irritability, pallor, vomiting, ECG changes, sudden collapse
IVIG reactionFever, chills, hypotension, wheeze, rash during infusion
Rheumatic carditis / heart failureNew murmur, tachycardia, gallop, hepatomegaly, edema
Recurrent ARFNew joint pain or fever after a missed prophylaxis dose
Reye syndrome (aspirin)Persistent vomiting, lethargy, confusion after a viral illness
Decompensated shockHypotension, altered mental status, bradycardia
Hypertensive emergencyHeadache, vision change, seizures
8.High-Yield Points
  • Kawasaki: fever 5 days or more + 4 of 5 (bilateral non-purulent conjunctivitis, cracked lips/strawberry tongue, rash, swollen red hands and feet then peeling, unilateral cervical node 1.5 cm or more)
  • Main risk: coronary artery aneurysm — echocardiograms at diagnosis, 1–2 weeks, and 4–6 weeks
  • IVIG 2 g/kg over 8–12 hours within 10 days + aspirin (moderate or high dose, then low dose 3–5 mg/kg/day)
  • IVIG: monitor like a transfusion; delay live vaccines 11 months
  • Aspirin in KD: inactivated flu vaccine, report varicella or flu exposure (Reye), no ibuprofen
  • Rheumatic fever follows GAS pharyngitis by 2–4 weeks; Jones criteria; carditis causes permanent mitral valve damage
  • Secondary prophylaxis: benzathine penicillin G IM every 3–4 weeks for years — adherence is the priority
  • Shock in children: tachycardia and delayed capillary refill come first; hypotension is late
  • Septic shock: antibiotics within 1 hour, 10–20 mL/kg boluses with reassessment, epinephrine or norepinephrine
  • BP measured with the correct cuff size; stage 1 hypertension at or above the 95th percentile

Country Notes

United States

  • Kawasaki disease is the leading cause of acquired heart disease in US children; acute rheumatic fever is rare and seen mostly in children from endemic regions.
  • Annual BP screening from age 3 and universal lipid screening at 9–11 and 17–21 years follow AAP and NHLBI recommendations.

Philippines

  • Rheumatic heart disease remains a significant burden in Filipino children and young adults; secondary prophylaxis adherence (injection dates, supply, pain) is a central nursing task.
  • Kawasaki disease is diagnosed with the same criteria; children of Asian ancestry have a higher incidence.

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.